Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Last trade$2.24
Day change-$0.105 (-4.49%)
Day range$2.16 – $2.37
Volume197,087
Market cap$39M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$38.52M
Price / earnings
—
Price / book
1.04×
Price / sales
2.2×
EV / sales
1.33×
EV / EBITDA
-1.81×
Profitability
Earnings per share
-$0.94
Return on assets
-37.53%
Return on equity
-42.01%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
8.71×
Quick ratio
4.44×
Cash ratio
3.51×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$6.97M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SRTS, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$2.29M
$3.39M
$4.94M
$6.88M
$7.32M
$8.34M
$13.07M
$8.84M
Cost of revenue
$1.52M
$2.4M
$3.04M
$4.17M
$4.41M
$3.99M
$5.96M
$3.6M
Gross profit
$769K
$991K
$1.9M
$2.71M
$2.9M
$4.35M
$7.11M
$5.24M
Selling, general and administrative
$2.84M
$3.76M
$3.16M
$3.46M
$3.38M
$4.39M
$3.82M
$2.88M
Research and development
$1.11M
$1.59M
$1.88M
$1.82M
$1.47M
$2.61M
$1.56M
$863K
Total operating expenses
$3.95M
$5.35M
$5.05M
$5.28M
$4.85M
$7M
$5.38M
$3.75M
Operating income
-$3.18M
-$4.36M
-$3.15M
-$2.57M
-$1.94M
-$2.65M
$1.73M
$1.5M
Interest expense
$0
$0
$155K
$160K
$0
$0
$230K
$279K
Income before taxes
-$3.06M
-$4.23M
-$2.99M
-$2.41M
-$1.76M
-$2.46M
$1.96M
$1.77M
Income taxes
$5.69M
-$1.61M
$174K
-$1.47M
-$723K
$110K
$410K
$559K
Net income
-$8.75M
-$2.63M
-$3.17M
-$943K
-$1.04M
-$2.57M
$1.55M
$1.22M
Net income attributable to common shareholders
-$8.75M
-$2.63M
-$3.17M
-$943K
-$1.04M
-$2.57M
$1.55M
$1.22M
EBITDA
-$3.09M
-$4.26M
-$3.05M
-$2.47M
-$1.84M
-$2.56M
$1.81M
$1.55M
Basic earnings per share
-$0.53
-$0.16
-$0.19
-$0.06
-$0.06
-$0.16
$0.09
$0.07
Diluted earnings per share
-$0.53
-$0.16
-$0.19
-$0.06
-$0.06
-$0.16
$0.09
$0.07
Recent news
Company coverage with links to the original publishers.
Law firm investigating potential securities law violations by Marex Group after a research report alleging accounting irregularities caused stock price decline.
Law firm investigating potential securities law violations by Sensus Healthcare after company reported significant revenue decline and stock price drop in Q2 2025.
Bragar Eagel & Squire is investigating potential claims against AVITA Medical after the company reported a six-month backlog in unpaid provider claims for Recell procedures, which caused a 21% stock price decline.
Sensus Healthcare reported Q2 2025 financial results with lower revenue and earnings, leading to a significant stock price decline and potential securities fraud investigation by Portnoy Law Firm.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.